MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis

MLA

Toshiyuki Takahashi, et al. “MOG Antibody Disease Manifesting as Progressive Cognitive Deterioration and Behavioral Changes with Primary Central Nervous System Vasculitis.” Multiple Sclerosis and Related Disorders, vol. 30, Sept. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bb18f877d5a1921bdb47a5fe25bda9a6&authtype=sso&custid=ns315887.

APA

Toshiyuki Takahashi, Mitsuru Watanabe, Toshikazu Baba, Dai Matsuse, Noriko Isobe, Shoko Sadashima, Kimihiko Kaneko, Ryo Yamasaki, Jun Ichi Kira, Koji Shinoda, & Toru Iwaki. (2018). MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis. Multiple Sclerosis and Related Disorders, 30.

Chicago

Toshiyuki Takahashi, Mitsuru Watanabe, Toshikazu Baba, Dai Matsuse, Noriko Isobe, Shoko Sadashima, Kimihiko Kaneko, et al. 2018. “MOG Antibody Disease Manifesting as Progressive Cognitive Deterioration and Behavioral Changes with Primary Central Nervous System Vasculitis.” Multiple Sclerosis and Related Disorders 30 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bb18f877d5a1921bdb47a5fe25bda9a6&authtype=sso&custid=ns315887.